Recent Updates
Recently added Catalysts
PTCT Neutral Sentiment

PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B. Klein, M.D., will present at the 44th Annual J.P. Morgan Healthcare...

Thursday, December 18, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: PTC Therapeutics, Inc. has announced that CEO Matthew B. Klein, M.D., will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. The presentation is scheduled for 9 a.m. PST/12 p.m. EST and will be webcast live. Interested participants can access the presentation via the company's website, and it will remain available for 30 days post-event. This event highlights the company's ongoing engagement with investors and the healthcare community.
Price reaction · baseline $74.94 (2025-12-17 close) · hit after-hours · 5 other PTCT headline(s) in the window, move may be shared
day 0 close
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • PTC Therapeutics is participating in a prestigious healthcare conference.
  • The presentation will be accessible live and archived for future viewing.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis

Full Press Release Details

WARREN, N.J. , Dec. 18, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that CEO Matthew B. Klein, M.D., will present at the 44 th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 9 a.m. PST/12 p.m. EST.
The presentation will be webcast live on the Events and Presentations page of the Investors section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations, and it will be archived for 30 days following the presentation.
For More Information:

Frequently Asked Questions

When is PTC Therapeutics presenting at the J.P. Morgan Conference?

PTC Therapeutics will present on January 12, 2026, at 9 a.m. PST.

Where can I watch the presentation live?

The presentation can be viewed on PTC Therapeutics' Investors page.

How long will the presentation be archived?

The presentation will be available for 30 days after the event.

Who is the CEO of PTC Therapeutics?

The CEO of PTC Therapeutics is Dr. Matthew B. Klein.

ShareAdd on Google
Tags: PTCT Viatris Investor Conferences Healthcare PTC Therapeutics J.P. Morgan Healthcare Conference Matthew Klein biopharma conference NASDAQ: PTCT
Last updated: Dec 18, 2025

Biotech snapshot

Cash runway
$2229M liquidity · $0M/mo burn
Low dilution risk
Lead asset
AtalurenPhase 3
Cystic Fibrosis →

Catalyst track record

+74%
best trade around PTCT's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for PTCT.

See every catalyst's timing & PoA →